{"ticker": {"uuid": "33e17fc1-801e-413e-97e8-c754be65c26a", "symbol": "MEL", "name": "Meli\u00e1 Hotels International, S.A.", "exchange": "MCE", "country": "ES", "sector": "Consumer Cyclical", "industry": "Lodging"}, "articles": [{"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.06, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, {"title": "Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate", "summary": "Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half year 2026 sales of \u20ac57.9 million and net income of \u20ac7.5 million, compared with \u20ac42.3 million and \u20ac1.5 million a year earlier, which sharpened investor focus on the stock. Those figures, together with basic earnings per share from continuing operations of \u20ac0.211 compared with \u20ac0.043 a year ago, provide fresh data to reassess ", "url": "https://finance.yahoo.com/markets/stocks/articles/bittium-oyj-hlse-bitti-earnings-181044517.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:10:44+00:00", "published_display": "07 Aug 2026 18:10", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.098, "duplicate_count": 1, "topics": ["Balance Sheet", "Defense", "Earnings", "Earnings Growth", "Earnings Per Share", "Net Income"]}], "by_tier": {"direct": [{"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.06, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, {"title": "Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate", "summary": "Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half year 2026 sales of \u20ac57.9 million and net income of \u20ac7.5 million, compared with \u20ac42.3 million and \u20ac1.5 million a year earlier, which sharpened investor focus on the stock. Those figures, together with basic earnings per share from continuing operations of \u20ac0.211 compared with \u20ac0.043 a year ago, provide fresh data to reassess ", "url": "https://finance.yahoo.com/markets/stocks/articles/bittium-oyj-hlse-bitti-earnings-181044517.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:10:44+00:00", "published_display": "07 Aug 2026 18:10", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.098, "duplicate_count": 1, "topics": ["Balance Sheet", "Defense", "Earnings", "Earnings Growth", "Earnings Per Share", "Net Income"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 185, "call_budget": 500, "budget_used_pct": 37.0, "requests_made": 37, "last_success_at": "2026-08-13T05:00:28.226703+00:00", "newest_seen_at": "2026-08-13T04:31:14+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3530, "unmapped_mentions": 1787}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 59, "raw_score": 70, "total": 2, "evidence_count": 2, "effective_articles": 1.89, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 17, "confidence": 46, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-07T18:22:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 75, "events": [{"event": "earnings", "label": "Earnings", "weight": 1.2, "count": 2}], "positive_events": 1, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 185, "call_budget": 500, "budget_used_pct": 37.0, "requests_made": 37, "last_success_at": "2026-08-13T05:00:28.226703+00:00", "newest_seen_at": "2026-08-13T04:31:14+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3530, "unmapped_mentions": 1787}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 10.17, "latest_week": "2026-08-07", "one_week_move": -1.6, "four_week_move": -8.9, "twelve_week_move": -13.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.985304, "market_dynamics_buy_signal": false, "relative_strength": -2.502404, "fair_value_gap": 37.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.9804, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.6% over one week, -8.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Positive news being faded", "tone": "negative", "classification": "positive_rejected", "summary": "Constructive headlines are not being rewarded by price, which raises a rejection flag.", "confidence": 57, "badges": ["Sentiment confirms active trend", "Positive but stretched"], "opportunities": ["Constructive tone aligns with the Sharemaestro trend signal."], "risks": ["Constructive tone is arriving with price materially above fair value."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "46/100", "tone": "neutral", "text": "1.89 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Positive news being faded", "tone": "negative", "text": "Constructive headlines are not being rewarded by price, which raises a rejection flag."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "17/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.6% over one week, -8.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong"}], "updated_at": "2026-08-13T05:05:12.738395+00:00", "detail_intelligence": {"headline": "Positive news being faded", "summary": "Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 59, "display": "59", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 46, "display": "46", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 83, "display": "83", "tone": "positive", "note": "17/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 24, "note": "1.89 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 39, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 83, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 39, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 2, "score": 70, "tone": "positive", "x": 683.2, "y": 98.6, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 866.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "683.2,98.6", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": 70, "delta": null, "recent_count": 0, "prior_count": 2, "volume_delta": -2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 2, "share": 100}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 70, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 2, "share": 100, "score": 70, "tone": "positive"}], "topics": [{"label": "Earnings", "count": 2, "share": 100}, {"label": "Pharma", "count": 1, "share": 50}, {"label": "Net Income", "count": 1, "share": 50}, {"label": "Fourth Quarter", "count": 1, "share": 50}, {"label": "Fda Approval", "count": 1, "share": 50}, {"label": "Earnings Per Share", "count": 1, "share": 50}, {"label": "Earnings Growth", "count": 1, "share": 50}, {"label": "Defense", "count": 1, "share": 50}, {"label": "Clinical Trials", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to MEL."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 83/100, indicating a comparatively coherent tape."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Price disagreement", "text": "Constructive headlines are not being rewarded by price, which raises a rejection flag."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong", "summary": "Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due to higher SG&A expenses tied to costs associated with the commercial launch of Myqorzo and lower revenues. Revenues amounted to $28.6 million, which went down from $66.8 million in the year-ago quarter but surpassed the Zacks Consensus Estimate of $20 million. Cytokinetics' shares have surged 28.1% year to date compared with the ind", "url": "https://finance.yahoo.com/healthcare/articles/cytk-q2-earnings-top-estimates-182200106.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T18:22:00+00:00", "published_display": "07 Aug 2026 18:22", "sentiment": "neutral", "sentiment_pct": 48, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.06, "duplicate_count": 1, "topics": ["Biotech", "Clinical Trials", "Earnings", "Fda Approval", "Fourth Quarter", "Pharma"]}, "article_count": 2, "updated_at": "2026-08-13T04:00:31.007390+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 204.2, "label": "13 Feb 2026", "close": 7.88, "index": 100.0}, {"x": 78.6, "y": 196.6, "label": "20 Feb 2026", "close": 8.11, "index": 102.9}, {"x": 115.3, "y": 188.6, "label": "27 Feb 2026", "close": 8.34, "index": 105.8}, {"x": 151.9, "y": 199.5, "label": "06 Mar 2026", "close": 8.02, "index": 101.8}, {"x": 188.6, "y": 181.2, "label": "13 Mar 2026", "close": 8.56, "index": 108.6}, {"x": 225.2, "y": 166.3, "label": "20 Mar 2026", "close": 9.0, "index": 114.2}, {"x": 261.8, "y": 151.0, "label": "27 Mar 2026", "close": 9.45, "index": 119.9}, {"x": 298.5, "y": 133.7, "label": "03 Apr 2026", "close": 9.96, "index": 126.4}, {"x": 335.1, "y": 106.6, "label": "10 Apr 2026", "close": 10.76, "index": 136.5}, {"x": 371.8, "y": 81.2, "label": "17 Apr 2026", "close": 11.51, "index": 146.1}, {"x": 408.4, "y": 86.3, "label": "24 Apr 2026", "close": 11.36, "index": 144.2}, {"x": 445.0, "y": 94.8, "label": "01 May 2026", "close": 11.11, "index": 141.0}, {"x": 481.7, "y": 88.0, "label": "08 May 2026", "close": 11.31, "index": 143.5}, {"x": 518.3, "y": 71.4, "label": "15 May 2026", "close": 11.8, "index": 149.7}, {"x": 555.0, "y": 82.9, "label": "22 May 2026", "close": 11.46, "index": 145.4}, {"x": 591.6, "y": 90.7, "label": "29 May 2026", "close": 11.23, "index": 142.5}, {"x": 628.2, "y": 104.9, "label": "05 Jun 2026", "close": 10.81, "index": 137.2}, {"x": 664.9, "y": 84.5, "label": "12 Jun 2026", "close": 11.41, "index": 144.8}, {"x": 701.5, "y": 55.8, "label": "19 Jun 2026", "close": 12.26, "index": 155.6}, {"x": 738.2, "y": 61.5, "label": "26 Jun 2026", "close": 12.09, "index": 153.5}, {"x": 774.8, "y": 70.5, "label": "03 Jul 2026", "close": 11.83, "index": 150.1}, {"x": 811.4, "y": 93.1, "label": "10 Jul 2026", "close": 11.16, "index": 141.6}, {"x": 848.1, "y": 112.4, "label": "17 Jul 2026", "close": 10.59, "index": 134.4}, {"x": 884.7, "y": 117.5, "label": "24 Jul 2026", "close": 10.44, "index": 132.5}, {"x": 921.4, "y": 120.9, "label": "31 Jul 2026", "close": 10.34, "index": 131.2}, {"x": 958.0, "y": 126.6, "label": "07 Aug 2026", "close": 10.17, "index": 129.1}], "sentiment_points": [{"x": 712.5, "y": 122.6, "label": "21 Jun 2026", "score": 54}, {"x": 713.1, "y": 122.6, "label": "21 Jun 2026", "score": 54}, {"x": 718.2, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 719.9, "y": 126.3, "label": "22 Jun 2026", "score": 52}, {"x": 722.2, "y": 126.3, "label": "22 Jun 2026", "score": 52}, {"x": 724.4, "y": 124.5, "label": "23 Jun 2026", "score": 53}, {"x": 744.9, "y": 126.3, "label": "27 Jun 2026", "score": 52}, {"x": 746.5, "y": 128.2, "label": "27 Jun 2026", "score": 51}, {"x": 750.0, "y": 128.2, "label": "28 Jun 2026", "score": 51}, {"x": 760.7, "y": 126.3, "label": "30 Jun 2026", "score": 52}, {"x": 761.9, "y": 130.0, "label": "30 Jun 2026", "score": 50}, {"x": 775.6, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 778.8, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 779.6, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 780.6, "y": 124.5, "label": "04 Jul 2026", "score": 53}, {"x": 806.8, "y": 126.3, "label": "09 Jul 2026", "score": 52}, {"x": 818.9, "y": 117.1, "label": "11 Jul 2026", "score": 57}, {"x": 822.0, "y": 119.0, "label": "12 Jul 2026", "score": 56}, {"x": 835.0, "y": 115.3, "label": "14 Jul 2026", "score": 58}, {"x": 839.1, "y": 115.3, "label": "15 Jul 2026", "score": 58}, {"x": 855.3, "y": 115.3, "label": "18 Jul 2026", "score": 58}, {"x": 856.5, "y": 115.3, "label": "18 Jul 2026", "score": 58}, {"x": 870.5, "y": 115.3, "label": "21 Jul 2026", "score": 58}, {"x": 870.8, "y": 115.3, "label": "21 Jul 2026", "score": 58}, {"x": 871.1, "y": 115.3, "label": "21 Jul 2026", "score": 58}, {"x": 878.7, "y": 115.3, "label": "22 Jul 2026", "score": 58}, {"x": 915.5, "y": 126.3, "label": "29 Jul 2026", "score": 52}, {"x": 918.3, "y": 126.3, "label": "30 Jul 2026", "score": 52}, {"x": 929.2, "y": 124.5, "label": "01 Aug 2026", "score": 53}, {"x": 934.5, "y": 124.5, "label": "02 Aug 2026", "score": 53}, {"x": 943.7, "y": 126.3, "label": "04 Aug 2026", "score": 52}], "price_path": "42.0,204.2 78.6,196.6 115.3,188.6 151.9,199.5 188.6,181.2 225.2,166.3 261.8,151.0 298.5,133.7 335.1,106.6 371.8,81.2 408.4,86.3 445.0,94.8 481.7,88.0 518.3,71.4 555.0,82.9 591.6,90.7 628.2,104.9 664.9,84.5 701.5,55.8 738.2,61.5 774.8,70.5 811.4,93.1 848.1,112.4 884.7,117.5 921.4,120.9 958.0,126.6", "sentiment_path": "712.5,122.6 713.1,122.6 718.2,120.8 719.9,126.3 722.2,126.3 724.4,124.5 744.9,126.3 746.5,128.2 750.0,128.2 760.7,126.3 761.9,130.0 775.6,122.6 778.8,124.5 779.6,124.5 780.6,124.5 806.8,126.3 818.9,117.1 822.0,119.0 835.0,115.3 839.1,115.3 855.3,115.3 856.5,115.3 870.5,115.3 870.8,115.3 871.1,115.3 878.7,115.3 915.5,126.3 918.3,126.3 929.2,124.5 934.5,124.5 943.7,126.3", "price_change": 29.1, "sentiment_change": -2, "latest_close": 10.17, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}